Impaired redox status and cytochrome c oxidase deficiency in patients with polymyalgia rheumatica

P Chariot1, X Chevalier, M Yerroum

  • 1Department of Pathology (Neuromuscular Disorders), Hôpital Henri-Mondor, 94000 Créteil, France. pchariot@cybercable.fr

Abstract

Insights

Polymyalgia rheumatica (PMR) is linked to muscular mitochondrial issues, including cytochrome c oxidase (COX) deficiency. These abnormalities suggest PMR involves mitochondrial dysfunction beyond normal aging.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Rheumatology

Background:

  • Polymyalgia rheumatica (PMR) is an inflammatory condition primarily affecting older adults.
  • The underlying pathophysiology of PMR, particularly concerning muscle involvement, remains incompletely understood.
  • Mitochondrial dysfunction is implicated in various age-related and inflammatory diseases.

Purpose of the Study:

  • To investigate redox status and muscular mitochondrial abnormalities in patients diagnosed with polymyalgia rheumatica (PMR).
  • To determine if observed mitochondrial changes in PMR are attributable solely to the aging process.

Main Methods:

  • Prospective analysis of deltoid muscle biopsies from 15 PMR patients and 15 age- and sex-matched controls.
  • Histochemical staining for cytochrome c oxidase (COX) and other markers, along with Sudan black staining.
  • Measurement of blood lactate, pyruvate, and lactate/pyruvate ratio in all participants.

Main Results:

  • Focal COX deficiency was prevalent in PMR patients (93%) and controls (60%), but significantly more common in PMR patients.
  • Ragged red fibres, indicative of mitochondrial abnormalities, were observed in 53% of PMR patients.
  • Elevated blood lactate levels or lactate/pyruvate ratios were found in 47% of PMR patients.

Conclusions:

  • Polymyalgia rheumatica (PMR) is associated with significant muscular mitochondrial abnormalities.
  • These mitochondrial alterations in PMR are not solely a consequence of the natural aging process.
  • The findings suggest a role for mitochondrial dysfunction in the pathogenesis of PMR.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...